



Medical Geneticist.—The Division of Human Genetics
in the Department of Pediatrics at the University of
California, Irvine, is seeking a faculty member at the
associate or full professor level with experience and ex-
pertise in medical genetics. The successful candidate
should have an M.D. or M.D./Ph.D. and be ABMG
eligible/certified in clinical genetics. The successful can-
didate will be expected to develop an active research
program and to accept the directorship of a clinical ser-
vice. It is expected that the candidate will qualify for
appointment in the faculty senate series of Clinical X
with demonstrated expertise in clinical and teaching ac-
tivities. The chosen individual will be expected to spear-
head the development of an integrated program in hu-
man genetics uniting basic scientists and clinicians.
Interested candidates should send a curriculum vitae and
three references to Jay Gargus, M.D., Ph.D., Search
Committee Chairman, UCI Medical Center, Department
of Pediatrics, Building 2, 3rd Floor, ZOT 4482, 101 The
City Drive, Orange, CA 92868. The University of Cal-
ifornia, Irvine, is an equal opportunity employer com-
mitted to excellence through diversity.
Bioinformatics/Computational Biology.—The Division
of Human Cancer Genetics at Ohio State University has
an immediate opening for a tenure-track position at the
assistant professor level. Candidates should have a
strong commitment to research, a background in bioin-
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formatics/computational science, and interest in devel-
oping their own bioinformatics research group. Priority
will be given to those candidates with an interest in
developing novel tools for the analysis of complex data
sets, including gene expression; DNA microarrays; and
expression and methylation data generated by genome-
wide scans using Gene-chip, cDNA, or custom DNA
arrays and RLGS. A highly competitive recruiting pack-
age is available, which includes an attractive salary, new
office space, and substantial start-up funds. The Human
Cancer Genetics program is rapidly expanding under the
leadership of Dr. Albert de la Chapelle, and it contains
both basic and clinical components. The program is
affiliated with the Comprehensive Cancer Center and
the Arthur G. James Cancer Hospital and Solove Re-
search Institute and the Department of Medical Micro-
biology and Immunology. The Ohio State University
campus includes an NIH-funded Comprehensive Cancer
Center, the College of Medicine and Public Health, the
nearby College of Biological Sciences, and other colleges
with comprehensive undergraduate and graduate pro-
grams. Applications should include a detailed curricu-
lum vitae, a description of research experience, and a
statement concerning the nature of the planned inde-
pendent research program. Information about the Uni-
versity and the Division of Human Cancer Genetics can
be obtained at our Web sites (http://www.osu.edu or
http://phenotype.med.ohio-state.edu). Informal inquiries
may be directed to Dr. Christoph Plass at (614) 292-
6505. Application material should be sent to Bioinfor-
matics Search Committee, c/o Brad Harris, The Ohio
State University Division of Human Cancer Genetics,
646 Medical Research Facility, 420 West 12th Avenue,
Columbus OH 43210. The Ohio State University is an
equal opportunity/affirmative action employer.Qualified
women, minorities, Vietnam-era veterans, and individ-
uals with disabilities are encouraged to apply.
Clinical Cytogeneticist/Assistant Professor.—The Hay-
ward Genetics Center seeks a clinical cytogeneticist for
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an assistant professor position at Tulane University
School of Medicine. The successful applicant will be
ABMG certified or eligible in clinical cytogenetics. Ad-
ditional ABMG board certification or eligibility in clin-
ical molecular genetics or clinical genetics is desired. The
Hayward Genetics Center conducts an active clinical and
cytogenetics service. Ample opportunity for collabora-
tion with basic scientists within the center and through-
out the medical school is available. Interested persons
should send a curriculum vitae and the names of three
references to Jess G. Thoene, M.D., Professor and Chair,
Hayward Genetics Center, Box SL#31, Tulane University
School of Medicine, 1430 Tulane Avenue, New Orleans,
LA 70112. Tulane University is an equal opportunity/
affirmative action employer, and applications from qual-
ified women and minority-group members are especially
encouraged.
Tenure-Track Assistant/Associate Professor.—As part of
a University-wide programmatic expansion in genetics
and genomics, the Department of Biometry and Genetics
at Louisiana State University Health Sciences Center in
New Orleans invites applications for a tenure-track fac-
ulty position at the assistant or associate professor level.
Applicants must hold a Ph.D. and/or an M.D. degree
with postdoctoral experience in genetics, genomics, or
computational biology and must have demonstrated the
ability to develop an extramurally funded, independent
research program. The successful candidate will be a
member of the Molecular and Human Genetics Center
and will enjoy excellent space and state-of-the-art equip-
ment. Contributing to the graduate andmedical teaching
of the Department is expected. Please send a curriculum
vitae, a description of research interests, and at least
three letters of reference to Bronya Keats, Ph.D., De-
partment of Biometry and Genetics, LSUHealth Sciences
Center, 1901 Perdido Street, New Orleans, LA 70112.
LSUHSC is an equal opportunity/affirmative action
employer. A drug test is required.
Executive Director, American College of Medical Ge-
netics.—The American College of Medical Genetics
seeks an outstanding person to serve as its first Executive
Director. This individual will also serve as Executive Di-
rector of the American College of Medical Genetics
Foundation. A doctoral degree is required; an M.D. is
desirable. Preference will be given to Diplomates of the
American Board of Medical Genetics. Association-
management experience is also preferred. The successful
candidate will have effective communication skills and
demonstrated success in managing a substantial organ-
ization. He or she will develop a business plan—with
emphasis on fund raising, professional development, and
recognition of medical geneticists—and will implement
the College’s strategic plan, which is currently being fi-
nalized. The position will be based in metropolitan
Washington, D.C., and the Executive Director will re-
port to the Board of Directors through the President.
Salary commensurate with qualifications; excellent ben-
efits. Part-time applicants will be considered. Applica-
tions will be accepted until the position is filled. Send
an application with a curriculum vitae and the names
of three professional references to R. Rodney Howell,
M.D., President, American College of Medical Genetics,
c/o FASEB Human Resources Deparment, 9650 Rock-
ville Pike, Bethesda, MD 20814-3998. Equal opportu-
nity employer.
Clinical Geneticist.—The Mayo Clinic’s Department of
Medical Genetics is seeking a clinical geneticist for its
expanding program in inborn errors of metabolism. All
applicants must have the M.D. degree and be board
certified or eligible for board certification in clinical ge-
netics and biochemical genetics by the American Board
of Medical Genetics. The Department of Medical Ge-
netics currently coordinates a multidisciplinary inborn
errors of metabolism clinic and interacts extensivelywith
the Division of Laboratory Genetics in clinical and re-
search efforts in biochemical genetics. The successful
candidate will also be expected to participate in the gen-
eral genetics clinical service, education, and research ac-
tivities. Academic rank and salary will be commensurate
with experience. A curriculum vitae, a cover letter de-
tailing experience and future interests, and the names of
three individuals who can provide letters of recommen-
dation should be sent to Jerry Vockley, M.D., Ph.D.,
Professor and Chair, Department of Medical Genetics,
Mayo Clinic, 200 First Street SW, Rochester,MN55905;
fax: (507) 284-4601 or (507) 284-3757. E-mail: vockley
@mayo.edu
Clinical Cancer Geneticist.—The Barbara Ann Karma-
nos Cancer Institute and the Center for Molecular Med-
icine and Genetics at Wayne State University School of
Medicine are seeking a clinical cancer geneticist to fur-
ther develop and lead the Cancer Genetics Clinic at the
assistant or associate professor level. We are soliciting
outstanding candidates with interest and expertise in
clinical cancer genetics. Participation in collaborative
cancer genetics–related clinical research projects is ex-
pected. Applicants should be certified or eligible for cer-
tification in clinical genetics by the American Board of
Medical Genetics and should have either an M.D. or an
M.D./Ph.D. Excellent core facilities for genomics activ-
ities are available in support of cancer genetics research,
and clinical genetics services are available for collabo-
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rative efforts in pediatric genetics, reproductive genetics,
and neurogenetics. The large and diverse patient pop-
ulation of the Detroit Medical Center provides excellent
opportunities for research. The Barbara Ann Karmanos
Institute operates one of the leading nationally recog-
nized cancer research, treatment, education, and out-
reach centers in the United States. In addition to the
RRC-approved medical genetics residency program, the
Center provides graduate and postdoctoral research
training and ABMG-accredited training programs in
clinical genetics, clinical cytogenetics, clinical biochem-
ical genetics, and clinical molecular genetics. For further
information, please contact Jerry Feldman, M.D., Ph.D.,
FACMG, Director, Clinical Genetics Services, Center for
Molecular Medicine and Genetics, Wayne State Univer-
sity School of Medicine, 540 East Canfield, 3216 Scott
Hall, Detroit, MI 48201; telephone: (313) 577-6298;
fax: (313) 577-5218; e-mail: glfeldman@pol.net. Wayne
State University School of Medicine, the country’s larg-
est single-campus medical school, is an equal opportu-
nity/affirmative action employer.
Molecular Geneticist in Aging and Neurodegenerative
Disease.—The Oregon Aging and Alzheimer’s Disease
Center in the Department of Neurology at Oregon
Health Sciences University is seeking candidates for a
position as assistant or associate professor in molecular
genetics. Applicants must have experience in state-of-
the-art human molecular genetics techniques and will be
expected to establish an independently funded research
program in the genetics of aging and neurodegenerative
disease. The successful candidate will join a collaborative
team of clinical and basic scientists and will have access
to large collections of relevant patient material. The ap-
plicant will also maintain and oversee the molecular ge-
netics laboratory of the Aging and Alzheimer’s Disease
Center as its director. Applicants should send a curric-
ulum vitae, three letters of reference, and a statement of
research interests to Dr. Jeffrey Kaye,MolecularGenetics
Search Committee, Department of Neurology, Oregon
Aging and Alzheimer Disease Center, CR131, Oregon
Health Sciences University, 3181 SW Sam Jackson Park
Road, Portland, OR, 97201. Oregon Health Sciences
University is an equal opportunity employer.
Molecular Geneticists.—Boston University School of
Medicine is seeking two molecular geneticists (one as-
sociate and one assistant professor) to participate in the
establishment of a newly funded laboratory affiliated
with the research activities of the Framingham Heart
Study. These openings may be filled immediately. The
Framingham Heart Study is a 50-year study of cardio-
vascular disease and has been actively involved in the
genetic epidemiology of this disease for the past 10 years.
Applicants will have academic appointments in the De-
partment of Medicine and in a newly formed Depart-
ment of Genetics. The candidates should have a doc-
torate in molecular biology or a related field. For the
Associate Professor position, the applicant should have
5–7 years of postdoctoral experience. Successful appli-
cants will participate actively in research projects for
pursuing candidate genes and the results of a 10-cM
genome scan recently performed for 334 extended fam-
ilies in the Framingham Study. Projects focus on the ge-
netic etiology of cardiovascular disease, but other op-
portunities in neurogenetics, osteoarthritis,osteoporosis,
and deafness may also be available. Boston University
is an equal opportunity employer. We encourage appli-
cations from women and minorities. The deadline for
receipt of applications is May 1, 2000. Applicants
should send a curriculum vitae and the names and ad-
dresses of three potential references to Richard H. My-
ers, Ph.D., Department of Neurology, B-603D, Boston
University School of Medicine, 715 Albany Street, Bos-
ton, MA 02118; telephone: (617) 638-5376; e-mail:
rmyers@bu.edu
CALL FOR PATIENTS
Call for Pregnant Mothers Already Caring for a Child
with a Transplant-Treatable Condition.—Children’s
Hospital Oakland has developed the first NIH-funded
(1-U24-HL61877-01) related-donor cord-blood (CB)
program. We facilitate collection, testing, transporta-
tion, and storage of cord blood free of charge for moth-
ers expecting a full sibling of a child diagnosed with a
transplant-treatable condition. CB is a viable source of
hematopoietic stem cells (HSCs). Collection of HSCs
from CB offers advantages over collection of HSCs from
bone marrow for use in transplantation: (1) CB HSCs
can be drawn without endangering the health of the
newborn or mother. (2) The immunologic immaturity of
CB likely decreases the incidence and severity of graft
versus host disease. (3) Recipients of CB HSCs might
tolerate an HLA mismatch. Since the program’s incep-
tion last year, we have collected 1200 CB units (CBUs).
We have released five CBUs for transplantation, and sev-
eral more have been requested. All recipients have en-
grafted, none have experienced significant graft versus
host disease, and four of the five are free from evidence
of their underlying disease. Participation in the program
does not mean that a decision to transplant has been
made. For more information, or to refer a patient for
CB collection, please contact the Related-Donor Cord
Blood Program, 5700 Martin Luther King Jr. Way, Oak-
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land, CA 94609; telephone: (510) 450–7605; fax: (510)
450-5839.
WORKSHOPS AND CONFERENCES
Workshop on “The Role of Genetics in Child Neuro-
psychiatry.”—Pisa, May 15–17, 2000. Organized by the
Stella Maris Scientific Research Institute, Division of
Child Neurology and Psychiatry, Department of Procre-
ative Medicine and Pediatrics, University of Pisa, and by
the Division of Medical Genetics, Department of Pedi-
atrics, University of Utah Health Sciences Center, Salt
Lake City. Scientific Committee: A. Battaglia, Pisa–Salt
Lake City; J. C. Carey, Salt Lake City; J. M. Opitz, Salt
Lake City; and P. Pfanner, Pisa. Workshop Faculty: A.
Bailey, London; A. Battaglia, Pisa–Salt Lake City; E.
Boncinelli, Milan; J. C. Carey, Salt Lake City; S. B. Cas-
sidy, Cleveland; B. Dallapiccola, Rome; J. A. Finegan,
Toronto; J. P. Fryns, Leuven; R. Guerrini, Pisa–London;
R. C. M. Hennekam, Amsterdam; K. Hirschhorn, New
York; M. Irons, Boston; C. Kleimola, Ypsilanti; M. J.
Labellarte, Baltimore; W. M. McMahon, Salt Lake City;
A. M. Meloni-Ehrig, Salt Lake City; C. A. Morris, Las
Vegas; J. M. Opitz, Salt Lake City; P. Pfanner, Pisa; V.
Rosato, Rome; R. E. Stevenson, Greenwood; D. H. Vis-
kochil, Salt Lake City; C. A. Williams, Gainesville; and
T. J. Wright, Salt Lake City. Price: LIT 300,000 ($160
U.S.) before February 29, 2000, or LIT 350,000 ($190
U.S.) after that date. The fee includes lunch and coffee
breaks. Scientific Secretariat: Dr. Agatino Battaglia,
Stella Maris Scientific Research Institute, Division of
Child Neurology and Psychiatry, Department of Procre-
ative Medicine and Pediatrics, University of Pisa, Via
dei Giacinti 2, 56018 Calambrone, Pisa, Italy; tele-
phone: 39 050 886248; fax: 39 050 32214; e-mail:
abattaglia@inpe.unipi.it
British Human Genetics Conference.—September
11–13, 2000, at the University of York, United King-
dom. Including a 1-day joint symposium on “Technol-
ogies in Genome Analysis” with the Genetical Society
on Wednesday, September 13. Other symposia will
include “From Cytogenetics to Epigenetics in 40
Years”—speakers Terry Hassold (Cleveland), Andrea
Ballabio (Milan), Wolf Reik (Cambridge), and Jean-
Louis Mandel (Strasbourg); and “Molecular Genetics of
Birth Defects Syndromes”—speakers En Li (Charles-
town, MA), Han Brunner (Nijmeen, Netherlands), and
Paolo Sassone-Corsi (Strasbourg). Joint symposiumwith
the Cancer Family Study Group: “P53 from Genetic
Practice into Theory”—speakers Pierre Hainault (Lyon),
Ros Eeles (Royal Marsden Hospital, Surrey), and Jenny
Varley (Christie Hospital, Manchester). Joint sympo-
sium with the Genetical Society: “Technologies in Ge-
nome Analysis”—speakers Jane Rogers (Sanger Centre,
Cambridge), J. M. Claverie (CNRS,Marseille, France),
Janet Thornton (UCL, London), David Bailey (De Novo
Pharmaceuticals, Cambridge), Ed Southern (Deparment
of Biochemistry, Cambridge), Mike Bevan (JIC, Nor-
wich), and Patrick Brown (Stanford University). The
Carter Lecture will be given by Dr. Francis Collins (Na-
tional Human Genome Research Institute, USA) on
“Medical and Societal Consequences of the Human Ge-
nome Project.” Workshops will include “Counseling for
Adolescents and Adults with Cognitive Impairment,”
“Emerging Technologies in Molecular Diagnostics,”
“Chromosome Breakage,” “Chromatin Remodelling
and Gene Expression,” and plenary sessions. Further
information is available from the Conference Office,
British Society for Human Genetics, Clinical Genetics
Unit, Birmingham Women’s Hospital, Edgbaston, Bir-
mingham B15 2TG, United Kingdom; telephone/fax:
44 0121 627 2634; e-mail: bshg@bham.ac.uk; Web
site: http://www.bham.ac.uk/bshg
Workshop on Primed In Situ Labeling (PRINS).—The
First International PRINSWorkshop will be held Sunday
and Monday, July 23–24, 2000, at the Ramada Plaza
Beach Resort in Fort Walton Beach, Florida. This will
immediately follow the Southern Genetics Group Meet-
ing at the same location. The workshop, sponsored in
part by the March of Dimes, will highlight the emerging
PRINS technology as a cost-effective alternative to FISH
for routine use in research and diagnosis. The devel-
opment of PRINS is a significant biologic milestone, be-
cause every known gene sequence is a potential primer
source. It follows that any gene or exon should be iden-
tifiable in chromosome preparations in situ, provided
that the unique nucleotide sequence is available. Topics
to be discussed include detection of repetitive DNA
sequences and mapping of unique sequences, identifica-
tion of chromosomal aneuploidies and marker chro-
mosomes, detection of microdeletions, gene mapping,
evaluation of telomeres, tandem labeling of satellite
DNA, recent technical advances, PRINS in the study of
abnormal sex differentiation, and PRINS in cancer de-
tection. The speakers have contributed substantially to
the development of the technology. The meeting will be
open on a “first come, first served” basis to 100 partic-
ipants. The material is directed to clinicians, laboratory
heads, young and established investigators, graduate stu-
dents, technical trainees, and others. There will be pro-
visions for posters selected on the basis of submitted
abstracts. The registration fee for the Workshop is
$60.00. For further information, contact the organizers,
Dr. Stephen S. Wachtel and Dr. Avirachan T. Tharapel,
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First International PRINS Workshop, University of Ten-
nessee, Memphis, 711 Jefferson Avenue, Room 523,
Memphis, TN 38105; fax: (901) 448-4117; e-mail:
swachtel@utmem.edu
COURSE
Summer Institute in Forensic Sciences.—The Royal Ca-
nadian Mounted Police and Carleton University are
hosting an intensive weeklong Summer Institute in Fo-
rensic Sciences for June 4–9, 2000. Courses are on topics
in Forensic Sciences. The course “Interpretation of DNA
Evidence in Casework” may be of particular interest.
Contact the School of Continuing Education, Carleton
University, Room 302 Robertson Hall, 1125 Colonel By
Drive, Ottawa, ON K1S 5B6; telephone: (613) 520-
3500; fax: (613) 520-3502; e-mail: bernadette_landry
@carleton.ca or conted@carleton.ca. Web site: http://
www.carleton.ca/forensics/
